AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Chiome Bioscience Inc.
  3. Financials
  4. Revenue growth (%)

Chiome Bioscience Inc.【JP:4583】

Market cap
¥7.4B
P/E ratio
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRevenue growth (%) YoY (%)
Dec 31, 2025-24-266.69%
Dec 31, 202414.4+75.95%
Dec 31, 20238.2-171.09%
Dec 31, 2022-11.5-123.87%
Dec 31, 202148.3+549.53%
Dec 31, 20207.4-93.26%
Dec 31, 2019110.3-709.28%
Dec 31, 2018-18.1-693.44%
Dec 31, 20173.1-130.62%
Dec 31, 2016-10-68.97%
Dec 31, 2015-32.1-24.44%
Dec 31, 2014-42.5-255.72%
Mar 31, 201427.3-155.89%
Mar 31, 2013-48.8-232.96%
Mar 31, 201236.7

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)